The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Fluorine in Medicinal Chemistry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Organofluorine Chemistry: Principles and Commercial Applications
(1994) · doi:10.1007/978-1-4899-1202-2 · Cited by 1,691
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Fluorine substituent effects (on bioactivity)
Smart, B. E. (2001) · Journal of Fluorine Chemistry · doi:10.1016/s0022-1139(01)00375-x · Cited by 1,497
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Barker, A. J., Gibson, K. H., Grundy, W., Godfrey, A. A., Barlow, J. J., Healy, M. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Scarlett, L., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00344-4 · Cited by 569
Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities
Morgenthaler, M., Schweizer, E., Hoffmann‐Röder, A., Benini, F., Martin, R. E., Jaeschke, G., Wagner, B., Fischer, H., Bendels, S., Zimmerli, D., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200700059 · Cited by 518
Orthogonal Multipolar Interactions in Structural Chemistry and Biology
Paulini, R., Müller, K., & Diederich, F. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462213 · Cited by 505
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
Cox, L. R., Thomas, E. J., & Clayden, J. (2007) · Cited by 496
The C–F bond as a conformational tool in organic and biological chemistry
Hunter, L. (2010) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.6.38 · Cited by 395
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212711200 · Cited by 336
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
Roffey, S. J., Cole, S., Comby, P., Gibson, D., Jezequel, S. G., Nedderman, A. N. R., Smith, D. A., Walker, D. K., & Wood, N. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.731 · Cited by 330
9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONE
Fried, J., & Sabo, E. F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01634a101 · Cited by 323
The human pharmacology of fluticasone propionate
Harding, S. M. (1990) · Respiratory Medicine · doi:10.1016/s0954-6111(08)80004-2 · Cited by 313
Van Heek, M., France, C. F., Compton, D. S., Mcleod, R. L., Yumibe, N. P., Alton, K. B., Sybertz, E. J., & Davis, H. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36992-7 · Cited by 305
McCormack, P. L. (2011) · Drugs · doi:10.2165/11208240-000000000-00000 · Cited by 224
Hale, J. J., Mills, S. G., MacCoss, M., Finke, P. E., Cascieri, M. A., Sadowski, S., Ber, E., Chicchi, G. G., Kurtz, M., Metzger, J., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980299k · Cited by 207
Phillipps, G. H. (1990) · Respiratory Medicine · doi:10.1016/s0954-6111(08)80003-0 · Cited by 197
Fluorine as a Hydrogen‐Bond Acceptor: Experimental Evidence and Computational Calculations
Dalvit, C., Invernizzi, C., & Vulpetti, A. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201402858 · Cited by 195
Fluorinated nucleosides: Synthesis and biological implication
Liu, P., Sharon, A., & Chu, C. K. (2008) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2008.06.007 · Cited by 183
Selective fluorination of alkyl C–H bonds via photocatalysis
Kee, C. W., Chin, K. F., Wong, M. W., & Tan, C.-H. (2014) · Chem. Commun. · doi:10.1039/c4cc01848f · Cited by 171
The evolution of amidine-based brain penetrant BACE1 inhibitors
Oehlrich, D., Prokopcová, H., & Gijsen, H. J. M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.025 · Cited by 163
Marquez, V. E., Ezzitouni, A., Russ, P., Siddiqui, M. A., Ford, Feldman, R. J., Mitsuya, H., George, C., & Barchi, J. J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973535+ · Cited by 162
Cox, C. D., Coleman, P. J., Breslin, M. J., Whitman, D. B., Garbaccio, R. M., Fraley, M. E., Buser, C. A., Walsh, E. S., Hamilton, K., Schaber, M. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800386y · Cited by 160
Hilpert, H., Guba, W., Woltering, T. J., Wostl, W., Pinard, E., Mauser, H., Mayweg, A. V. W., Rogers‐Evans, M., Humm, R., Krummenacher, D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400225m · Cited by 148
Edwards, M. P., & Price, D. A. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45023-x · Cited by 147
Acquired QT interval prolongation and HERG: implications for drug discovery and development
Finlayson, K., Witchel, H. J., McCulloch, J., & Sharkey, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.019 · Cited by 147
Myers, A. G., Barbay, J. K., & Zhong, B. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010113y · Cited by 145
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
Black, W. C., Bayly, C. I., Davis, D. E., Desmarais, S., Falgueyret, J., Léger, S., Li, C. S., Massé, F., McKay, D. J., Palmer, J. T., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.071 · Cited by 142
Vulpetti, A., Hommel, U., Landrum, G. A., Lewis, R. A., & Dalvit, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905207t · Cited by 128
Barry, A. L., & Brown, S. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1948 · Cited by 123
Lauble, H., Kennedy, M. C., Emptage, M. H., Beinert, H., & Stout, C. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13699 · Cited by 121
On the polarity of partially fluorinated methyl groups
Huchet, Q. A., Kuhn, B., Wagner, B., Fischer, H., Kansy, M., Zimmerli, D., Carreira, E. M., & Müller, K. (2013) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2013.02.023 · Cited by 119
Nieschalk, J., Batsanov, A. S., O’Hagan, D., & Howard, J. A. K. (1996) · Tetrahedron · doi:10.1016/0040-4020(95)00890-k · Cited by 114
Rowley, M., Hallett, D. J., Goodacre, S. C., Moyes, C. R., Crawforth, J. M., Sparey, T. J., Patel, S. S., Marwood, R., Patel, S., Thomas, S., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0004998 · Cited by 114
Deng, X., Kokkonda, S., Mazouni, F. E., White, J. C., Burrows, J. N., Kaminsky, W., Charman, S. A., Matthews, D. J., Rathod, P. K., & Phillips, M. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500481t · Cited by 113
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K
Isabel, É., Mellon, C., Boyd, M. J., Chauret, N., Deschênes, D., Desmarais, S., Falgueyret, J., Gauthier, J. Y., Khougaz, K., Lau, C. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.070 · Cited by 111
Pinard, M. A., Boone, C. D., Magalis, B. R., Supuran, C. T., & McKENNA, R. V. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.033 · Cited by 110
A new class of carbonic anhydrase inhibitor.
Maren, T. H., & Conroy, C. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74305-1 · Cited by 108
Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency
Hajduk, P. J., & Sauer, D. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070838y · Cited by 107
Bergman, A. J., Ebel, D. L., Liu, F., Stone, J. A., Wang, A., Zeng, W., Chen, L., Dilzer, S. C., Lasseter, K. C., Herman, G. A., et al. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.560 · Cited by 103
Review of recent advances in nucleophilic C–F bond-forming reactions at sp3 centers
Wu, J. Y.-C. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.06.006 · Cited by 100
Reck, F., Alm, R. A., Brassil, P. J., Newman, J. V., Ciaccio, P. J., McNulty, J. M., Barthlow, H. G., Goteti, K., Breen, J. N., Comita-Prevoir, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300690s · Cited by 96
Topical drug delivery to the eye: dorzolamide
Loftsson, Þ., Jansook, P., & Stefánsson, E. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02299.x · Cited by 87
DICKINSON, R. P., Bell, A., Hitchcock, C. A., Narayanaswami, S., Ray, S. J., Richardson, K., & Troke, P. F. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00363-0 · Cited by 85
Volonterio, A., Bellosta, S., Bravin, F. M., Bellucci, M. C., Bruche, L. A. C., Colombo, G., Malpezzi, L., Mazzini, S., Meille, S. V., Meli, M., et al. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200304881 · Cited by 80
Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors
Xu, J., Ok, H., Gonzalez, E. J., Colwell, L. F., Habulihaz, B., He, H., Leiting, B., Lyons, K. A., Marsilio, F., Patel, R. A., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.099 · Cited by 79
GOLDSTEIN, D. M., Soth, M., Gabriel, T., Dewdney, N. J., Kuglstatter, A., Arzeno, H. B., Chen, J., BINGENHEIMER, W., Dalrymple, S. A., Dunn, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101423y · Cited by 77
Interaction of glucocorticoid analogues with the human glucocorticoid receptor
Berger, T. S., Parandoosh, Z., Perry, B. W., & Stein, R. B. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90414-e · Cited by 76
Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials
Sweeney, M. E., & Johnson, R. R. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.3.441 · Cited by 72
Kenny, P. W. (1994) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/p29940000199 · Cited by 71
Hale, J. J., Mills, S. G., MacCoss, M., Shah, S. K., Qi, H., Mathre, D. J., Cascieri, M. A., Sadowski, S. J., Strader, C. D., MacIntyre, D. E., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950654w · Cited by 68
Chauret, N., Guay, D., Li, C., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00349-9 · Cited by 60
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
Luker, T. J., Alcaraz, L., Chohan, K. K., Blomberg, N., Brown, D. S., Butlin, R. J., Elebring, T., Griffin, A. M., Guile, S. D., St-Gallay, S. A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.074 · Cited by 60
Self-citationWu, Y., Davis, C. D., Dworetzky, S. I., Fitzpatrick, W., Harden, D., He, H., Knox, R. J., Newton, A. E., Philip, T., Polson, C. T., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034111v · Cited by 60
Kim, D., Kowalchick, J. E., Edmondson, S. D., Mastracchio, A., Xu, J., Eiermann, G. J., Leiting, B., Wu, J. K., Pryor, K. D., Patel, R. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.098 · Cited by 58
Tashkin, D. P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.837159 · Cited by 57
Dossetter, A. G. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.077 · Cited by 52
Martínez‐Montero, S., Deleavey, G. F., Kulkarni, A. S., Martín‐Pintado, N., Lindovská, P., Thomson, M., González, C., Götte, M., & Damha, M. J. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo500794v · Cited by 51
Zhang, N., Zhang, X., Zhu, J., Turpoff, A., Chen, G., Morrill, C., Huang, S., Lennox, W., Kakarla, R., Liu, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401621g · Cited by 44
Earl, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1015 · Cited by 41
Barchi, J. J., Karki, R. G., Nicklaus, M. C., Siddiqui, M. A., George, C. F., Mikhailopulo, I. A., & Márquez, V. E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800964g · Cited by 40
Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Humphrey, J. M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451925 · Cited by 39
Ligand Structural Aspects of hERG Channel Blockade
Aronov, A. M. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785700061 · Cited by 38
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
Huskey, S.-E. W., Dean, B. J., Doss, G. A., Wang, Z., Hop, C. E. C. A., Anari, R., Finke, P. E., Robichaud, A. J., Zhang, M., Wang, B., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.246 · Cited by 38
4-Fluorosulfonylpiperidines: Selective 5-HT2A ligands for the treatment of insomnia
Fish, L. R., Gilligan, M. T., Humphries, A. C., Ivarsson, M., Ladduwahetty, T., Merchant, K. J., O'Connor, D. V., Patel, S. S., Philipps, E., Vargas, H. M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.104 · Cited by 37
Håkansson, K., & Liljas, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00798-5 · Cited by 36 · cited 1×
“The binding of this very potent but low-molecular-weight inhibitor, through interaction of the deprotonated sulphonamide with the active site metal, was subsequently demonstrated by solving the crystal structure of the enzyme inhibitor complex [25].”
BackgroundNovel CCR1 antagonists with improved metabolic stability
Brown, M. F., Avery, M., Brissette, W. H., Chang, J. H., Colizza, K., Conklyn, M. J., DiRico, A. P., Gladue, R. P., Kath, J. C., Krueger, S. S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.022 · Cited by 36
Pyridyl amides as potent inhibitors of T-type calcium channels
Reger, T. S., Yang, Z.-Q., Schlegel, K.-A. S., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.089 · Cited by 35
Shimizu, H., Yamasaki, T., Yoneda, Y., Muro, F., Hamada, T., Yasukochi, T., Tanaka, S., Toki, T., Yokoyama, M., Morishita, K., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.115 · Cited by 30
Dossetter, A. G., Douglas, A., & O'Donnell, C. (2012) · MedChemComm · doi:10.1039/c2md20155k · Cited by 28
Kath, J. C., DiRico, A. P., Gladue, R. P., Martin, W. H., McElroy, E. B., Stock, I. A., Tylaska, L. A., & Zheng, D. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.020 · Cited by 26
Weber, A. E., & Thornberry, N. A. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42007-3 · Cited by 21
Special Feature Organo-Fluorine Chemical Science
Hügel, H., & Jackson, N. (2012) · Applied Sciences · doi:10.3390/app2020558 · Cited by 21
Fluorinated Inhalation Anesthetics
Halpern, D. F. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1202-2_26 · Cited by 14
Cited by
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01877 · Cited by 719
Contemporary synthetic strategies in organofluorine chemistry
Britton, R., Gouverneur, V., Lin, J.-H., Meanwell, M., Ni, C., Pupo, G., Xiao, J.-C., & Hu, J. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00042-1 · Cited by 319
Kourounakis, A. P., Xanthopoulos, D., & Tzara, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21634 · Cited by 294
Directed Evolution of a Fluorinase for Improved Fluorination Efficiency with a Non‐native Substrate
Sun, H., Yeo, W. L., Lim, Y. H., Chew, X., Smith, D. J., Xue, B., Chan, K. P., Robinson, R. C., Robins, E. G., Zhao, H., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606722 · Cited by 54
Metadata
- Authors
- Swallow, S.
- Venue
- Progress in Medicinal Chemistry
- Publisher
- Elsevier
- Published
- 2015
- Volume
- 54
- Pages
- 65-133
- ISSN
- 0079-6468 (ISSN-L)
- OpenAlex
- W224505985
- Cited by
- 280
- References
- 85
- FWCI
- 36.74
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.